, Pharmacotherapeutics for Advanced Practice Nurse Prescribers 5th Edition Woo Robinson Test Bank
Chapter 1. The Role of the Nurse Practitioner
1.
A nurse practitioner (NP) is preparing to prescribe a Schedule II opioid for acute pain. Which principle best supports
safe and legal prescribing?
A. Relying on previous prescriber patterns
B. Prescribing the smallest effective dose for the shortest duration
C. Delegating the prescription to a medical assistant
D. Calling in a 30-day supply to reduce patient inconvenience
Answer: B
Rationale: Schedule II drugs have high abuse potential; prescribing minimal effective doses for brief durations aligns
with federal DEA and CDC guidelines and supports responsible opioid stewardship.
2.
The most critical difference between NP prescriptive authority and that of a physician is that:
A. NPs must always have direct supervision when prescribing
B. NP authority varies by state and may be restricted or collaborative
C. NPs cannot prescribe controlled substances
D. Physicians have no continuing education requirements
Answer: B
Rationale: Prescriptive authority for NPs depends on individual state Nurse Practice Acts and may require physician
collaboration or delegation, whereas physicians have unrestricted authority.
3.
Which federal agency primarily governs controlled substance prescribing for all licensed providers?
A. FDA
B. DEA
C. CMS
D. CDC
Answer: B
,Rationale: The Drug Enforcement Administration (DEA) enforces the Controlled Substances Act, regulates
registration, and monitors prescribing of scheduled drugs.
4.
When establishing a collaborative practice agreement, the NP should ensure the document:
A. Includes personal friendship terms
B. Specifies only billing arrangements
C. Outlines scope, responsibilities, and prescriptive limits
D. Eliminates shared accountability
Answer: C
Rationale: A well-written collaborative agreement defines scope of practice, prescriptive authority, and shared clinical
responsibilities, protecting both NP and physician legally.
5.
A key expectation of the NP as prescriber is to integrate pharmacotherapeutics with:
A. Institutional policies alone
B. Patient-specific clinical assessment and evidence-based guidelines
C. Brand-name preferences
D. Manufacturer protocols
Answer: B
Rationale: Safe prescribing merges pharmacologic knowledge with individualized patient assessment and current
clinical evidence to ensure optimal outcomes.
6.
A newly licensed NP is granted full prescriptive authority. This means the NP can:
A. Prescribe independently without mandated physician oversight
B. Prescribe only under a collaborative contract
C. Prescribe only noncontrolled drugs
D. Prescribe only within hospital settings
Answer: A
Rationale: Full practice authority (FPA) allows NPs to evaluate, diagnose, and prescribe independently—granted in
over half of U.S. states and several Canadian provinces.
7.
Which of the following most directly promotes rational drug prescribing?
A. Patient demand for brand-name medications
, B. Pharmaceutical representative influence
C. Application of pathophysiologic reasoning and evidence-based guidelines
D. Empiric repetition of prior prescriptions
Answer: C
Rationale: Rational prescribing bases drug selection on pathophysiology, patient factors, efficacy, safety, and
evidence—minimizing cost and error.
8.
A nurse practitioner’s DEA number primarily identifies:
A. The prescriber’s tax ID
B. Authorization to prescribe controlled substances
C. The NP’s state license
D. The practice location
Answer: B
Rationale: The DEA number signifies federal registration allowing controlled substance prescribing; it must appear on
each controlled prescription.
9.
When an NP prescribes a new medication, which step ensures shared decision-making?
A. Providing a pre-written prescription without explanation
B. Discussing therapeutic goals, risks, and alternatives
C. Focusing on cost only
D. Requiring patient consent without discussion
Answer: B
Rationale: Shared decision-making empowers patients, increases adherence, and respects autonomy—integral to
ethical prescribing.
10.
Which ethical principle underlies the NP’s responsibility to prescribe the most effective medication at the lowest
necessary risk?
A. Autonomy
B. Beneficence
C. Justice
D. Veracity
Answer: B
Chapter 1. The Role of the Nurse Practitioner
1.
A nurse practitioner (NP) is preparing to prescribe a Schedule II opioid for acute pain. Which principle best supports
safe and legal prescribing?
A. Relying on previous prescriber patterns
B. Prescribing the smallest effective dose for the shortest duration
C. Delegating the prescription to a medical assistant
D. Calling in a 30-day supply to reduce patient inconvenience
Answer: B
Rationale: Schedule II drugs have high abuse potential; prescribing minimal effective doses for brief durations aligns
with federal DEA and CDC guidelines and supports responsible opioid stewardship.
2.
The most critical difference between NP prescriptive authority and that of a physician is that:
A. NPs must always have direct supervision when prescribing
B. NP authority varies by state and may be restricted or collaborative
C. NPs cannot prescribe controlled substances
D. Physicians have no continuing education requirements
Answer: B
Rationale: Prescriptive authority for NPs depends on individual state Nurse Practice Acts and may require physician
collaboration or delegation, whereas physicians have unrestricted authority.
3.
Which federal agency primarily governs controlled substance prescribing for all licensed providers?
A. FDA
B. DEA
C. CMS
D. CDC
Answer: B
,Rationale: The Drug Enforcement Administration (DEA) enforces the Controlled Substances Act, regulates
registration, and monitors prescribing of scheduled drugs.
4.
When establishing a collaborative practice agreement, the NP should ensure the document:
A. Includes personal friendship terms
B. Specifies only billing arrangements
C. Outlines scope, responsibilities, and prescriptive limits
D. Eliminates shared accountability
Answer: C
Rationale: A well-written collaborative agreement defines scope of practice, prescriptive authority, and shared clinical
responsibilities, protecting both NP and physician legally.
5.
A key expectation of the NP as prescriber is to integrate pharmacotherapeutics with:
A. Institutional policies alone
B. Patient-specific clinical assessment and evidence-based guidelines
C. Brand-name preferences
D. Manufacturer protocols
Answer: B
Rationale: Safe prescribing merges pharmacologic knowledge with individualized patient assessment and current
clinical evidence to ensure optimal outcomes.
6.
A newly licensed NP is granted full prescriptive authority. This means the NP can:
A. Prescribe independently without mandated physician oversight
B. Prescribe only under a collaborative contract
C. Prescribe only noncontrolled drugs
D. Prescribe only within hospital settings
Answer: A
Rationale: Full practice authority (FPA) allows NPs to evaluate, diagnose, and prescribe independently—granted in
over half of U.S. states and several Canadian provinces.
7.
Which of the following most directly promotes rational drug prescribing?
A. Patient demand for brand-name medications
, B. Pharmaceutical representative influence
C. Application of pathophysiologic reasoning and evidence-based guidelines
D. Empiric repetition of prior prescriptions
Answer: C
Rationale: Rational prescribing bases drug selection on pathophysiology, patient factors, efficacy, safety, and
evidence—minimizing cost and error.
8.
A nurse practitioner’s DEA number primarily identifies:
A. The prescriber’s tax ID
B. Authorization to prescribe controlled substances
C. The NP’s state license
D. The practice location
Answer: B
Rationale: The DEA number signifies federal registration allowing controlled substance prescribing; it must appear on
each controlled prescription.
9.
When an NP prescribes a new medication, which step ensures shared decision-making?
A. Providing a pre-written prescription without explanation
B. Discussing therapeutic goals, risks, and alternatives
C. Focusing on cost only
D. Requiring patient consent without discussion
Answer: B
Rationale: Shared decision-making empowers patients, increases adherence, and respects autonomy—integral to
ethical prescribing.
10.
Which ethical principle underlies the NP’s responsibility to prescribe the most effective medication at the lowest
necessary risk?
A. Autonomy
B. Beneficence
C. Justice
D. Veracity
Answer: B
